7:18 PM
 | 
Nov 19, 2013
 |  BC Extra  |  Company News

DSM, private equity firm taking CRO Patheon private

Dutch chemicals company Royal DSM N.V. (Euronext:DSM) and private equity firm JLL Partners are teaming up to acquire CRO Patheon Inc. (TSX:PTI) for $9.32 per share in cash, which the partners said gives the CRO an enterprise value of about $2 billion. The...

Read the full 205 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >